National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers; Extension of Comment Period
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule on national standards for licensure for wholesale drug distributors and third-party logistics providers that appeared in the Federal Register of February 4, 2022. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.